Antiviral Effects of Stichopus Japonicus Acid Mucopolysaccharide on Hepatitis B Virus Transgenic Mice

Yongning Xin,Wei Li,Linlin Lu,Li Zhou,David W. Victor,Shiying Xuan
DOI: https://doi.org/10.1007/s11802-016-3124-4
2016-01-01
Journal of Ocean University of China
Abstract:Hepatitis B virus (HBV) is a significant global pathogen and efficient cure for HBV patients is still a challenging goal. We previously reported that acidic mucopolysaccharide from stichopus japonicus selenka (SJAMP) could inhibit HBsAg and HBeAg expression in vitro. However, the potential anti-HBV effects of SJAMP in vivo have not yet been explored. In this study, we show that SJAMP exhibits potent anti-HBV activity in HBV transgenic mice in a dose-dependent manner. Specifically, sixty HBV transgenic male BALB/c mice were randomly selected to receive the treatment of PBS, low dose SJAMP (30 mg kg−1), middle dose SJAMP (40 mg kg−1), high dose SJAMP (50 mg kg−1) and IFN (45 IU kg−1) for 30 d. SJAMP treatment suppressed serum HBV-DNA, and liver HBsAg and HBcAg levels in HBV-transgenic mice. The present study highlights the potential application of SJAMP in HBV therapy.
What problem does this paper attempt to address?